Autor Título Original / Colaboración Selecciona una opción Original Colaboración Año Selecciona un año2015201620172018201920202021202220232024 Cuartil Selecciona un cuartilD1Q1Q2Q3Q4 Tipo Selecciona un tipo#N/DArticleArtículoBook ChapterBook ReviewClinical TrialCommentaryCorrectionData PaperEditorialEditorial MaterialLetterProceedings PaperReprintReview Revista Rapid and simultaneous determination of histidine metabolism intermediates in human and mouse microbiota and biomatrices Autores: Acuna, I; Ruiz, A; Cerdo, T; Cantarero, S; Lopez-Moreno, A; Aguilera, M; Campoy, C; Suarez, A Nanomedicine as a Promising Tool to Overcome Immune Escape in Breast Cancer Autores: Navarro-Ocon, A; Blaya-Canovas, JL; Lopez-Tejada, A; Blancas, I; Sanchez-Martin, RM; Garrido, MJ; Grinan-Lison, C; Calahorra, J; Cara, FE; Ruiz-Cabello, F; Marchal, JA; Aptsiauri, N; Granados-Principal, S Progress and Hurdles of Therapeutic Nanosystems against Cancer Autores: Martin-Contreras, M; Navarro-Marchal, SA; Peula-Garcia, JM; Jodar-Reyes, AB Predicting dynamic response to neoadjuvant chemotherapy in breast cancer: a novel metabolomics approach Autores: Diaz, C; Gonzalez-Olmedo, C; Diaz-Beltran, L; Camacho, J; Garcia, PM; Martin-Blazquez, A; Fernandez-Navarro, M; Ortega-Granados, AL; Galvez-Montosa, F; Marchal, JA; Vicente, F; del Palacio, JP; Sanchez-Rovira, P Isogenic GAA-KO Murine Muscle Cell Lines Mimicking Severe Pompe Mutations as Preclinical Models for the Screening of Potential Gene Therapy Strategies Autores: Aguilar-Gonzalez, A; Gonzalez-Correa, JE; Barriocanal-Casado, E; Ramos-Hernandez, I; Lerma-Juarez, MA; Greco, S; Rodriguez-Sevilla, JJ; Molina-Estevez, FJ; Montalvo-Romeral, V; Ronzitti, G; Sanchez-Martin, RM; Martin, F; Munoz, P Incorporating the Gut Microbiome in the Risk Assessment of Xenobiotics and Identifying Beneficial Components for One Health Autores: Ampatzoglou, A; Gruszecka-Kosowska, A; Torres-Sanchez, A; Lopez-Moreno, A; Cerk, K; Ortiz, P; Monteoliva-Sanchez, M; Aguilera, M Isogenic GAA-KO Murine Muscle Cell Lines Mimicking Severe Pompe Mutations as Preclinical Models for the Screening of Potential Gene Therapy Strategies. Autores: Aguilar-Gonzalez, A; Gonzalez-Correa, JE; Barriocanal-Casado, E; Ramos-Hernandez, I; Lerma-Juarez, MA; Greco, S; Rodriguez-Sevilla, JJ; Molina-Estevez, FJ; Montalvo-Romeral, V; Ronzitti, G; Sanchez-Martin, RM; Martin, F; Munoz, P < 1 2 … 421 422 423 … 1.504 1.505 >
